A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy

Acquired chemotherapy resistance is a major contributor to treatment failure in oncology. For example, the efficacy of the common anticancer agent doxorubicin (DOX) is limited by the emergence of multidrug resistance (MDR) phenotype in cancer cells. While dose escalation of DOX can circumvent such r...

Descripción completa

Detalles Bibliográficos
Autores principales: Pramanik, Dipankar, Campbell, Nathaniel R., Das, Samarjit, Gupta, Sonal, Chenna, Venugopal, Bisht, Savita, Sysa-Shah, Polina, Bedja, Djahida, Karikari, Collins, Steenbergen, Charles, Gabrielson, Kathleen L., Maitra, Amarnath, Maitra, Anirban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2012
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442295/
https://www.ncbi.nlm.nih.gov/pubmed/22791660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442295/
https://www.ncbi.nlm.nih.gov/pubmed/22791660

Ejemplares similares